Login
Merck & Company NYSE: MRK
Merck & Co., Inc. provides healthcare solutions worldwide in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
| Name | Merck & Company |
| Ticker | MRK |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Price | 85.81 |
| 52W Low/High | 66.40 / 92.04 |
| Market cap | 217 B |
| 1Y Total Return |
3.63%
Above Average |
| 1Y Volatility |
31.68%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Merck & Co., Inc. provides healthcare solutions worldwide in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
Details
| Ticker | MRK |
| Name | Merck & Company |
| ISIN | US58933Y1055 |
| CUSIP | 58933Y105 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) |
|
Share as of 9/18/20
| Close Price | 85.81 |
| 52W Low/High | 66.40 / 92.04 |
| Market cap | 217 B |
| 1Y Total Return |
3.63%
Above Average |
| 1Y Volatility |
31.68%
Low Risk |
| Beta | 0.61 |
| PE (trailing) |
20.93
Average |
| 12M Dividends | 2.38 |
| Last Dividend Date | 9/14/20 |
| Dividend Yield | 2.77% |
Fin. Strength
| Net Profit Margin | 22.2% |
| Cash from Op. / Cur. Liabilities | 0.59 |
| Diluted Earnings / Share | 4.10 |
| ROE | 37.9% |
| ROIC | 18.1% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 1.3 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.12 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
47,194
|
44,368
|
41,260
|
40,015
|
39,444
|
40,249
|
|
| Gross Profit |
33,064
|
31,007
|
27,912
|
26,970
|
24,683
|
24,954
|
|
| R&D |
10,084
|
8,402
|
12,198
|
10,062
|
7,108
|
7,349
|
|
| EBITDA |
16,124
|
15,678
|
10,231
|
10,666
|
12,563
|
21,954
|
|
| Operating Income |
11,988
|
11,861
|
4,815
|
5,952
|
7,141
|
5,482
|
|
| Net Income exc. Extra |
10,478
|
9,362
|
1,341
|
5,086
|
5,133
|
9,851
|
|
| per Share | |||||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
4.10
|
3.57
|
0.50
|
1.84
|
1.81
|
3.38
|
|
| Dividend |
2.38
|
2.13
|
1.91
|
1.87
|
1.83
|
1.79
|
|
| Div. Yield (an.) |
3.08%
|
2.54%
|
3.15%
|
2.92%
|
3.18%
|
3.06%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
90,615
|
83,965
|
85,040
|
92,804
|
96,475
|
102,582
|
|
| Cash, Eq & Invt ShortTerm |
11,103
|
7,105
|
7,594
|
11,967
|
11,834
|
11,370
|
|
| Total Current Assets |
29,343
|
24,298
|
24,064
|
28,167
|
27,926
|
28,319
|
|
| Total Non-Current Assets |
61,272
|
59,667
|
60,976
|
64,637
|
68,549
|
74,263
|
|
| Intangibles |
36,633
|
32,871
|
31,172
|
34,477
|
38,124
|
42,457
|
|
| Total Liabilities |
62,871
|
56,228
|
52,274
|
53,092
|
53,029
|
55,944
|
|
| Total Current Liabilities |
22,178
|
20,085
|
18,128
|
18,758
|
14,918
|
17,508
|
|
| Long Term Debt |
40,693
|
36,143
|
34,146
|
34,334
|
38,111
|
38,436
|
|
| Shareholder equity |
27,642
|
27,635
|
32,529
|
39,463
|
43,357
|
46,448
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
13,094
|
10,805
|
7,385
|
10,206
|
11,330
|
8,053
|
|
| Depreciation |
3,650
|
3,963
|
4,748
|
4,715
|
6,241
|
6,429
|
|
| Cash from Investing |
-3,082
|
1,781
|
1,089
|
-1,387
|
-435
|
-598
|
|
| Capex |
3,750
|
2,959
|
2,189
|
1,692
|
1,463
|
1,284
|
|
| Cash from Financing |
-5,516
|
-11,169
|
-10,938
|
-7,569
|
-11,177
|
-8,694
|
|
| Stock Issued |
-3,639
|
-8,658
|
-3,633
|
-3,048
|
-3,546
|
-5,211
|
|
| Debt (LT) Issued |
4,282
|
3,202
|
-1,743
|
728
|
-2,374
|
1,465
|
|
| Free Cash Flow |
10,186
|
8,792
|
4,386
|
11,204
|
7,839
|
8,940
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
22.2%
|
21.1%
|
3.3%
|
12.7%
|
13.0%
|
24.5%
|
|
| NCFO / Op.Income |
109.2%
|
91.1%
|
153.4%
|
171.5%
|
158.7%
|
146.9%
|
|
| Current Ratio |
1.3
|
1.2
|
1.3
|
1.5
|
1.9
|
1.6
|
|
| Financial Leverage D/E |
1.12
|
0.96
|
0.72
|
0.63
|
0.56
|
0.57
|
|
| Return on Capital Avg |
18.1%
|
11.3%
|
2.6%
|
7.3%
|
7.6%
|
3.0%
|
|
| Return on Shareholder Equity |
37.9%
|
31.1%
|
3.7%
|
12.3%
|
11.4%
|
20.8%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available